FDA Inspection
New York Blood Center IncNew York Blood Center Inc – FDA Inspection, Feb 24, 2021
Record Details
This FDA Inspection record concerns New York Blood Center Inc, with an inspection on February 24, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- New York Blood Center Inc
- Inspection Date
- February 24, 2021
- Product Type
- Biologics
View Company Profile
ID · c6a3e9b1-d717-4cb1-85f7-7ec65954c9a1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1136000
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.60(b)Equipment calibration frequency
- 21 CFR 606.100(b)Written SOPs available for use by personnel
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2025 | VAI | New York District Office | Blood and Blood Products |
| May 1, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 6, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Inc
- FDA Inspection 1294968 - 2025-12-12
- FDA Inspection 1050701 - 2018-05-01
- FDA Inspection 969536 - 2016-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.